Literature DB >> 22098606

The lack of memory B cells including T cell independent IgM+ IgD+ memory B cells in chronic graft-versus host disease is associated with susceptibility to infection.

Inken Hilgendorf1, Brigitte Mueller-Hilke, Günther Kundt, Ernst Holler, Petra Hoffmann, Matthias Edinger, Mathias Freund, Daniel Wolff.   

Abstract

The chronic graft-versus host disease (cGVHD) is associated with a perturbed B cell homeostasis and an increased infection rate. Aiming to determine the impact of lymphocyte subsets on cGVHD, blood samples from 98 patients at least 100 days following allogeneic haematopoietic stem cell transplantation (median 1066 days) were analyzed, serum levels of immunoglobulins measured and the incidence of severe infections retrospectively documented. Absolute CD19(+) B cell counts, including counts of immature (CD10(+) CD38(++) CD20(+) IgM(++)) and transitional (CD10(-) CD38(++) CD20(+) IgM(++)) as well as class switched memory (CD19(+) CD27(+) IgM(-) IgD(-)) B cells in patients with active cGVHD (n = 52) were significantly decreased as compared to those with inactive (n = 18) or without cGVHD (n = 28). In addition, nonclass switched IgM(+) memory B cells (CD19(+) CD27(+) IgM(+) IgD(+)) were absent in patients with cGVHD, but not in patients with inactive (0.4 × 10(6) /l) or without (1.7 × 10(6) /l) cGVHD (both P < 0.001). In line with these results we found significantly decreased lgG levels in patients with cGVHD, which was associated with a significantly higher rate of severe infections in cGVHD patients. Our data underline the close association of diminished B cell counts with cGVHD and the onset of severe infections. The lack of IgM(+) memory B cells in patients with cGVHD may indicate functional asplenia.
© 2011 The Authors. Transplant International © 2011 European Society for Organ Transplantation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22098606     DOI: 10.1111/j.1432-2277.2011.01388.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  9 in total

1.  Functional hyposplenism after hematopoietic stem cell transplantation.

Authors:  J Rozmus; K Mallhi; J Ke; K R Schultz
Journal:  Bone Marrow Transplant       Date:  2015-07-13       Impact factor: 5.483

2.  Adoptive transfer of ex vivo expanded regulatory T cells improves immune cell engraftment and therapy-refractory chronic GvHD.

Authors:  Sybille Landwehr-Kenzel; Leonie Müller-Jensen; Joern-Sven Kuehl; Mohamed Abou-El-Enein; Henrike Hoffmann; Sandra Muench; Daniel Kaiser; Andy Roemhild; Horst von Bernuth; Mirjam Voeller; Michael Schmueck-Henneresse; Bernd Gruhn; Ulrik Stervbo; Nina Babel; Hans-Dieter Volk; Petra Reinke
Journal:  Mol Ther       Date:  2022-02-28       Impact factor: 12.910

3.  Comprehensive viromewide antibody responses by systematic epitope scanning after hematopoietic cell transplantation.

Authors:  Rachel A Bender Ignacio; Sayan Dasgupta; Terry Stevens-Ayers; Tomasz Kula; Joshua A Hill; Stephanie J Lee; Marco Mielcarek; Ann Duerr; Stephen J Elledge; Michael Boeckh
Journal:  Blood       Date:  2019-06-11       Impact factor: 25.476

4.  Sequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantation.

Authors:  Cristina Skert; Simone Perucca; Marco Chiarini; Viviana Giustini; Alessandra Sottini; Claudia Ghidini; Stefano Martellos; Federica Cattina; Benedetta Rambaldi; Valeria Cancelli; Michele Malagola; Alessandro Turra; Nicola Polverelli; Simona Bernardi; Luisa Imberti; Domenico Russo
Journal:  PLoS One       Date:  2017-04-11       Impact factor: 3.240

Review 5.  B Cell Reconstitution and Influencing Factors After Hematopoietic Stem Cell Transplantation in Children.

Authors:  Nicolaas G van der Maas; Dagmar Berghuis; Mirjam van der Burg; Arjan C Lankester
Journal:  Front Immunol       Date:  2019-04-12       Impact factor: 7.561

6.  Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD.

Authors:  Ahmad Khoder; Anushruti Sarvaria; Abdullah Alsuliman; Claude Chew; Takuya Sekine; Nichola Cooper; Stephan Mielke; Hugues de Lavallade; Muharrem Muftuoglu; Irina Fernandez Curbelo; Enli Liu; Paolo A Muraro; Amin Alousi; Kate Stringaris; Simrit Parmar; Nina Shah; Hila Shaim; Eric Yvon; Jeffrey Molldrem; Rayne Rouce; Richard Champlin; Ian McNiece; Claudia Mauri; Elizabeth J Shpall; Katayoun Rezvani
Journal:  Blood       Date:  2014-07-22       Impact factor: 22.113

7.  Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease-results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health.

Authors:  Daniel Wolff; Philipp Y Herzberg; Anne Herrmann; Steven Z Pavletic; Pia Heussner; Friederike Mumm; Christina Höfer; Inken Hilgendorf; Philipp G Hemmati; Ernst Holler; Hildegard Greinix; Sandra A Mitchell
Journal:  Bone Marrow Transplant       Date:  2020-07-31       Impact factor: 5.483

8.  Evidence for B Cell Exhaustion in Chronic Graft-versus-Host Disease.

Authors:  Ahmad Khoder; Abdullah Alsuliman; Rafet Basar; Catherine Sobieski; Kayo Kondo; Amin Majid Alousi; Richard Szydlo; Muharrem Muftuoglu; Hila Shaim; Jane F Apperley; Elif Gokdemir; Nichola Cooper; Rohtesh S Mehta; David Marin; Richard Champlin; Elizabeth Shpall; Katayoun Rezvani
Journal:  Front Immunol       Date:  2018-01-12       Impact factor: 7.561

9.  National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution.

Authors:  Anita Lawitschka; Ece Dila Gueclue; Angela Januszko; Ulrike Körmöczi; Arno Rottal; Gerhard Fritsch; Dorothea Bauer; Christina Peters; Hildegard T Greinix; Winfried F Pickl; Zoya Kuzmina
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.